[go: up one dir, main page]
More Web Proxy on the site http://driver.im/ Skip to main content

Advertisement

Springer Nature Link
Log in

P53-dependent antiproliferative and pro-apoptotic effects of trichostatin A (TSA) in glioblastoma cells

  • Laboratory Investigation
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Glioblastomas are known to be highly chemoresistant, but HDAC inhibitors (HDACi) have been shown to be of therapeutic relevance for this aggressive tumor type. We treated U87 glioblastoma cells with trichostatin A (TSA) to define potential epigenetic targets for HDACi-mediated antitumor effects. Using a cDNA array analysis covering 96 cell cycle genes, cyclin-dependent kinase inhibitor p21WAF1 was identified as the major player in TSA-induced cell cycle arrest. TSA slightly inhibited proliferation and viability of U87 cells, cumulating in a G1/S cell cycle arrest. This effect was accompanied by a significant up-regulation of p53 and its transcriptional target p21WAF1 and by down-regulation of key G1/S regulators, such as cdk4, cdk6, and cyclin D1. Nevertheless, TSA did not induce apoptosis in U87 cells. As expected, TSA promoted the accumulation of total acetylated histones H3 and H4 and a decrease in endogenous HDAC activity. Characterizing the chromatin modulation around the p21WAF1 promoter after TSA treatment using chromatin immunoprecipitation, we found (1) a release of HDAC1, (2) an increase of acetylated H4 binding, and (3) enhanced recruitment of p53. p53-depleted U87 cells showed an abrogation of the G1/S arrest and re-entered the cell cycle. Immunofluorescence staining revealed that TSA induced the nuclear translocation of p21WAF1 verifying a cell cycle arrest. On the other hand, a significant portion of p21WAF1 was present in the cytoplasmic compartment causing apoptosis resistance. Furthermore, TSA-treated p53-mutant cell line U138 failed to show an induction in p21WAF1, showed a deficient G2/M checkpoint, and underwent mitotic catastrophe. We suggest that HDAC inhibition in combination with other clinically used drugs may be considered an effective strategy to overcome chemoresistance in glioblastoma cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
£29.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (United Kingdom)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Wade PA et al (2001) Transcriptional control at regulatory checkpoints by histone deacetylases: molecular connections between cancer and chromatin. Hum Mol Genet 10:693–698

    Article  PubMed  CAS  Google Scholar 

  2. Ito K, Barnes PJ, Adcock IM et al (2000) Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12. Mol Cell Biol 20:6891–6903

    Article  PubMed  CAS  Google Scholar 

  3. Forsberg EC, Bresnick EH et al (2001) Histone acetylation beyond promoters: long-range acetylation patterns in the chromatin world. Bioessays 23:820–830. doi:10.1002/bies.1117

    Article  PubMed  CAS  Google Scholar 

  4. Kamitani H, Taniura S, Watanabe K, Sakamoto M, Watanabe T, Eling T et al (2002) Histone acetylation may suppress human glioma cell proliferation when p21 WAF/Cip1 and gelsolin are induced. Neuro-oncol 4:95–101

    PubMed  CAS  Google Scholar 

  5. Wetzel M, Premkumar D, Beth A, Pollack I et al (2005) Effect of trichostatin A, a histone deacetylase inhibitor, on glioma proliferation in vitro by inducing cell cycle arrest and apoptosis. J Neurosurg 103:549–556. doi:10.3171/ped.2005.103.6.0549

    PubMed  Google Scholar 

  6. Chen Z, Clark S, Birkeland M, Sung CM, Lago A, Liu R, Kirkpatrick R, Johanson K, Winkler JD, Hu E et al (2002) Induction and superinduction of growth arrest and DNA damage gene 45 (GADD45) alpha and beta messenger RNAs by histone deacetylase inhibitors trichostatin A (TSA) and butyrate in SW620 human colon carcinoma cells. Cancer Lett 188:127–140

    Article  PubMed  CAS  Google Scholar 

  7. Kim BY, Kim KA, Kwon O, Kim SO, Kim MS, Kim BS, Oh WK, Kim GD, Jung M, Ahn JS et al (2005) NF-kappaB inhibition radiosensitizes Ki-Ras-transformed cells to ionizing radiation. Carcinogenesis 26:1395–1403. doi:10.1093/carcin/bgi081

    Article  PubMed  CAS  Google Scholar 

  8. Ocker M, Schneider-Stock R et al (2007) Histone deacetylase inhibitors: signalling towards p21cip1/waf1. Int J Biochem Cell Biol 39:1367–1374. doi:10.1016/j.biocel.2007.03.001

    Article  PubMed  CAS  Google Scholar 

  9. Habold C, Poehlmann A, Bajbouj K, Hartig R, Korkmaz KS, Roessner A, Schneider-Stock R et al (2008) Trichostatin A causes p53 to switch oxidative-damaged colorectal cancer cells from cell cycle arrest into apoptosis. J Cell Mol Med 12:607–621. doi:10.1111/j.1582-4934.2007.00136.x

    Article  PubMed  CAS  Google Scholar 

  10. Castedo M, Perfettini JL, Roumier T, Andreau K, Medema R, Kroemer G et al (2004) Cell death by mitotic catastrophe: a molecular definition. Oncogene 23:2825–2837

    Article  PubMed  CAS  Google Scholar 

  11. Saito A, Yamashita T, Mariko Y, Nosaka Y, Tsuchiya K, Ando T, Suzuki T, Tsuruo T, Nakanishi O et al (1999) A synthetic inhibitor of histone deacetylase, MS-27–275, with marked in vivo antitumor activity against human tumors. Proc Natl Acad Sci USA 96:4592–4597

    Article  PubMed  CAS  Google Scholar 

  12. Burgess AJ, Pavey S, Warrener R, Hunter LJ, Piva TJ, Musgrove EA, Saunders N, Parsons PG, Gabrielli BG et al (2001) Up-regulation of p21(WAF1/CIP1) by histone deacetylase inhibitors reduces their cytotoxicity. Mol Pharmacol 60:828–837

    PubMed  CAS  Google Scholar 

  13. Archer SY, Meng S, Shei A, Hodin RA et al (1998) p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells. Proc Natl Acad Sci USA 95:6791–6796

    Article  PubMed  CAS  Google Scholar 

  14. Marks PA, Rifkind RA, Richon VM, Breslow R, Miller T, Kelly WK et al (2001) Functional significance of histone deacetylase diversity. Nat Rev Cancer 1:194–202

    Article  PubMed  CAS  Google Scholar 

  15. Richon VM, Sandhoff TW, Rifkind RA, Marks PA et al (2000) Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation. Proc Natl Acad Sci USA 97:10014–10019. doi:10.1073/pnas.180316197

    Article  PubMed  CAS  Google Scholar 

  16. Coqueret O et al (2003) New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? Trends Cell Biol 13:65–70

    Article  PubMed  CAS  Google Scholar 

  17. Rodriguez-Vilarrupla A, Diaz C, Canela N, Rahn HP, Bachs O, Agell N et al (2002) Identification of the nuclear localization signal of p21(cip1) and consequences of its mutation on cell proliferation. FEBS Lett 531:319–323

    Article  PubMed  CAS  Google Scholar 

  18. Asada M, Yamada T, Ichijo H, Delia D, Miyazono K, Fukumuro K, Mizutani S et al (1999) Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation. EMBO J 18:1223–1234. doi:10.1093/emboj/18.5.1223

    Article  PubMed  CAS  Google Scholar 

  19. Finnin MS, Donigian JR, Cohen A, Richon VM, Rifkind RA, Marks PA, Breslow R, Pavletich NP et al (1999) Structures of a histone deacteylase homologue bound to the TSA and SAHA inhibitors. Nature 401:188–191. doi:10.1038/43710

    Article  PubMed  CAS  Google Scholar 

  20. Baek S, Kim S, Bae M, Hwang J, Kim J, Choi Y, Wee H, Kim B, Kim J, Bae S et al (2005) Trichostatin A increases the thermosensitivity of human glioblastoma A172 cells. Neurosci Lett 23:230–234. doi:10.1016/j.neulet.2005.11.041

    Google Scholar 

  21. Kim JH, Shin JH, Kim IH et al (2004) Susceptibility and radiosensitization of human glioblastoma cells to trichostatin A, a histone deacetylase inhibitor. Int J Radiat Oncol Biol Phys 59:1174–1180. doi:10.1016/j.ijrobp.2004.03.001

    Article  PubMed  CAS  Google Scholar 

  22. Wang ZM, Hu J, Zhou D, Xu ZY, Panasci LC, Chen ZP et al (2002) Trichostatin A inhibits proliferation and induces expression of p21WAF and p27 in human brain tumor cell lines. Chin J Cancer 21:1100–1105

    Google Scholar 

  23. Mariadason J, Corner G, Augenlicht L et al (2000) Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer. Cancer Res 60:4561–4572

    PubMed  CAS  Google Scholar 

  24. Ragione F, Criniti V, Pietra V, Borriello A, Oliva A, Indaco S, Yamamoto T, Zappia V et al (2001) Genes modulated by histone acetylation as new effectors of butyrate activity. FEBS Lett 499:199–204

    Article  PubMed  Google Scholar 

  25. Bagui TK, Mohapatra S, Haura E, Pledger WJ et al (2003) P27Kip1 and p21Cip1 are not required for the formation of active D cyclin-cdk4 complexes. Mol Cell Biol 23:7285–7290

    Article  PubMed  CAS  Google Scholar 

  26. Gartel AL, Tyner AL et al (1999) Trancriptional regulation of the p21 ((WAF1/CIP1)) gene. Exp Cell Res 246:280–289. doi:10.1006/excr.1998.4319

    Article  PubMed  CAS  Google Scholar 

  27. Lee H, Lee S, Baek M, Kim HY, Jeoung DI et al (2002) Expression profile analysis of trichostatin A in human gastric cancer cells. Biotechnol Lett 24:377–381

    Article  Google Scholar 

  28. Gartel AL, Tyner AL et al (1997) Trancriptional regulation of the p21 ((WAF1/CIP1)) gene. Exp Cell Res 246:280–289

    Article  Google Scholar 

  29. Sowa Y, Orita T, Minamikawa S, Nakano K, Mizuno T, Nomura H, Sakai T et al (1997) Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites. Biochem Biophys Res Commun 241:142–150. doi:10.1006/bbrc.1997.7786

    Article  PubMed  CAS  Google Scholar 

  30. Poehlmann A, Habold C, Walluscheck D, Reissig K, Bajbouj K, Ullrich O, Hartig R, Gali-Muhtasib H, Diestel A, Roessner A, Schneider-Stock R et al. (2011) Cutting edge: Chk1 directs senescence and mitotic catastrophe in recovery from G(2) checkpoint arrest. J Cell Mol Med 15:1528–1541

    Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Institute of Pathology, University of Magdeburg, 39120, Magdeburg, Germany

    K. Bajbouj, A. Roessner & R. Schneider-Stock

  2. Institute of Neuropathology, University of Magdeburg, 39120, Magdeburg, Germany

    C. Mawrin & A. Wilisch-Neumann

  3. Institute of Immunology, University of Magdeburg, 39120, Magdeburg, Germany

    R. Hartig

  4. Experimental Tumorpathology, Institute of Pathology, University of Erlangen-Nuremberg, Universitätsstrasse 22, 91054, Erlangen, Germany

    J. Schulze-Luehrmann & R. Schneider-Stock

  5. Department of Biology, United Arab Emirates University, Al-Ain, UAE

    K. Bajbouj

Authors
  1. K. Bajbouj
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Mawrin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Hartig
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. Schulze-Luehrmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Wilisch-Neumann
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Roessner
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. R. Schneider-Stock
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. Schneider-Stock.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bajbouj, K., Mawrin, C., Hartig, R. et al. P53-dependent antiproliferative and pro-apoptotic effects of trichostatin A (TSA) in glioblastoma cells. J Neurooncol 107, 503–516 (2012). https://doi.org/10.1007/s11060-011-0791-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-011-0791-2

Keywords

Search

Navigation